KPF
PHGE icon

K2 Principal Fund’s BiomX PHGE Stock Holding History

K2 Principal Fund’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-87
Closed -$161K – 298
2019
Q4 		$161K Sell
87
-1,942
-96% -$3.35M 0.01% 274
2019
Q3 		$3.91M Buy
2,029
+1,770
+683% +$3.47M 0.42% 90
2019
Q2 		$461K Buy
+259
New +$481K 0.06% 229

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

K2 Principal Fund's PHGE Position: Q1 2020 in Review

K2 Principal Fund sold out of BiomX (PHGE) in Q1 2020, closing a stake of 87 shares — an estimated $161K sold.

K2 Principal Fund first reported a position in PHGE in Q2 2019 and held it in 3 quarters. The position peaked at $3.91M in Q3 2019. 10 funds tracked by Wall St. Rank hold PHGE as of Q1 2020.

  • K2 Principal Fund reported no remaining BiomX position as of Q1 2020 after selling out during the quarter.
  • K2 Principal Fund sold 87 BiomX shares in Q1 2020, an estimated $161K.
  • K2 Principal Fund first reported a position in BiomX in Q2 2019 and held it in 3 quarters.
  • K2 Principal Fund's BiomX position peaked at $3.91M in Q3 2019.
  • 10 funds tracked by Wall St. Rank held BiomX as of Q1 2020.

Based on K2 Principal Fund's 13F filing for Q1 2020, filed 15 May 2020.